ConvaTec Group PLC (LON:CTEC) Receives GBX 306 Consensus Target Price from Analysts

ConvaTec Group PLC (LON:CTEC) has received a consensus recommendation of “Moderate Buy” from the nine ratings firms that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is GBX 306.

A number of analysts have recently weighed in on the company. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 300 price objective on shares of ConvaTec Group in a research report on Monday, June 8th. JPMorgan Chase & Co. decreased their target price on ConvaTec Group from GBX 307 to GBX 294 and set an “overweight” rating for the company in a report on Friday, May 22nd. Citigroup lowered their target price on ConvaTec Group from GBX 250 to GBX 230 and set a “neutral” rating for the company in a research note on Monday, May 18th. Berenberg Bank restated a “buy” rating and set a GBX 340 price target on shares of ConvaTec Group in a report on Tuesday, April 21st. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 315 price target on shares of ConvaTec Group in a research report on Wednesday, April 8th.

Insider Activity at ConvaTec Group

In other news, insider Jonny Mason bought 50,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 26th. The shares were purchased at an average cost of GBX 201 per share, for a total transaction of £100,500. Corporate insiders own 0.98% of the company’s stock.

ConvaTec Group Price Performance

ConvaTec Group stock opened at GBX 216 on Wednesday. The company has a quick ratio of 0.96, a current ratio of 1.53 and a debt-to-equity ratio of 99.96. ConvaTec Group has a 52-week low of GBX 193 and a 52-week high of GBX 259.30. The firm has a market cap of £4.22 billion, a PE ratio of 25.12, a price-to-earnings-growth ratio of 0.93 and a beta of 0.76. The company’s 50 day moving average is GBX 207.86 and its two-hundred day moving average is GBX 222.77.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.